James Hambro & Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-16,090
Closed -$1.12M 52
2025
Q1
$1.12M Hold
16,090
0.05% 30
2024
Q4
$1.38M Hold
16,090
0.05% 30
2024
Q3
$1.92M Hold
16,090
0.08% 29
2024
Q2
$2.3M Hold
16,090
0.11% 28
2024
Q1
$2.07M Buy
16,090
+1,000
+7% +$128K 0.1% 30
2023
Q4
$1.56M Buy
+15,090
New +$1.56M 0.08% 31